Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Top
  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal
  • Top
  • Abstract
  • Version history
  • Article usage
  • Citations to this article

Advertisement

Research Article Free access | 10.1172/JCI106026

Formation of iodoprotein during the peripheral metabolism of 35,3′-triiodo-l-thyronine-125I in the euthyroid man and rat

Martin I. Surks and Jack H. Oppenheimer

1Endocrine Research Laboratory, Medical Division, Montefiore Hospital and Medical Center and the Department of Medicine, Albert Einstein College of Medicine, Bronx, New York 10467

Find articles by Surks, M. in: PubMed | Google Scholar

1Endocrine Research Laboratory, Medical Division, Montefiore Hospital and Medical Center and the Department of Medicine, Albert Einstein College of Medicine, Bronx, New York 10467

Find articles by Oppenheimer, J. in: PubMed | Google Scholar

Published April 1, 1969 - More info

Published in Volume 48, Issue 4 on April 1, 1969
J Clin Invest. 1969;48(4):685–695. https://doi.org/10.1172/JCI106026.
© 1969 The American Society for Clinical Investigation
Published April 1, 1969 - Version history
View PDF
Abstract

3,5,3′-Triiodo-L-thyronine-125I (T3-125I) metabolism was studied in nine euthyroid human subjects on blocking doses of nonradioactive iodide. After the intravenous injection of T3-125I, the fractional disappearance rate of plasma radioactivity progressively disappearance rate of plasma radioactivity progressively decreased with time. Analysis of individual plasma samples by dialysis, electrophoretic, and extraction techniques revealed three radioactive components: T3-125I, iodide-125I, and an unidentified material which was nonextractable in acid butanol (NE125I). Ne125I rose to maximal levels 24-36 hr after injection of T3-125I and then decreased with a fractional rate which approached, after 12-14 days, approximately 0.05 day-1 (t½ = 14 days). The plasma T3-125I concentration, obtained by subtraction of iodide-125I and NE125I from the plasma total 125I, declined at a constant fractional rate with time with a t½ of 1.5 days. Qualitatively similar results were obtained in rats. After 72 hr, 57% of the plasma and 40% of the liver radioactivity was NE125I. Chromatographic purification of the T3-125I before injection did not alter these results. The extrathyroidal origin of NE125I was further demonstrated by similar results in thyroidectomized rats maintained on thyroxine. NE125I from human sera separated from the other radioiodinated substances by ion-exchange chromatography was quantitatively precipitated by trichloracetic acid, not dialyzable, insoluble in CHCl3:CH2OH, and migrated with albumin during starch-gel electrophoresis. Based on these properties, NE125I was tentatively identified as iodoalbumin. Observations in rats equilibrated with 125I, as well as nonradioactive iodine determinations in human sera before and after acid butanol extraction, indicate that 10-20% of the serum organic iodine is in the form of iodoprotein. Our studies suggest that this moiety may be derived at least in part from the peripheral metabolism of the thyroid hormones.

Images.

Browse pages

Click on an image below to see the page. View PDF of the complete article

icon of scanned page 685
page 685
icon of scanned page 686
page 686
icon of scanned page 687
page 687
icon of scanned page 688
page 688
icon of scanned page 689
page 689
icon of scanned page 690
page 690
icon of scanned page 691
page 691
icon of scanned page 692
page 692
icon of scanned page 693
page 693
icon of scanned page 694
page 694
icon of scanned page 695
page 695
Version history
  • Version 1 (April 1, 1969): No description

Article tools

  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal

Metrics

  • Article usage
  • Citations to this article

Go to

  • Top
  • Abstract
  • Version history
Advertisement
Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts